What is Japan Tobacco Inc. (JAPAF)?

Japan Tobacco Inc. (JAPAF) is a stock in the Consumer Defensive sector, Tobacco industry. View full analysis on Stocks360.

What is the current price of JAPAF?

The current price of JAPAF is $45.10. Prices are updated in real time on Stocks360.

What is JAPAF's price-to-earnings (PE) ratio?

JAPAF's trailing twelve-month PE ratio is 20.69, based on current price and earnings per share data available on Stocks360.

What is JAPAF's market capitalization?

JAPAF's market capitalization is $80,068,627,399.00, placing it in the large-cap tier.

Does JAPAF pay a dividend?

Yes. JAPAF has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Japan Tobacco Inc. (JAPAF)

Stock analysis · OTC · Consumer Defensive · Tobacco

$45.10

Market Cap

$80.07B

PE (TTM)

20.69

EPS (TTM)

N/A

Dividend Yield

3.70%

Beta

0.13

Day Range

$45.10 – $48.55

52-wk Range

$33.53 – $48.55

Avg Volume

N/A

Volume

1.00K

Japan Tobacco Inc. (JAPAF) is a publicly traded company in the Consumer Defensive sector. Latest price: $45.10. Market cap $80.07B. Trailing PE 20.69. Dividend yield 3.70%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $33.99 2026-10-29 · $45.10 (+32.69%)

Earnings

Most Recent

Oct 29, 2026

EPS $0.67 vs est. $0.71

Missed by $0.04

Next Earnings

Feb 16, 2027

EPS estimate $0.11

Proprietary Signals

Signal snapshot temporarily unavailable.

About Japan Tobacco Inc.

Japan Tobacco Inc. (JTI) is a diversified global enterprise that manufactures and distributes tobacco products, pharmaceuticals, and various processed foods. Its operations are organized into four distinct divisions: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. JTI's comprehensive tobacco portfolio includes traditional offerings like cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products, sold under prominent brands such as Winston, Camel, MEVIUS, and LD. Additionally, the company is a key player in the reduced-risk product (RRP) market, offering solutions like tobacco-infused vapor and heated tobacco devices, as well as E-Vapor products, marketed under brands including Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S. Beyond tobacco, JTI's pharmaceutical arm engages in the research, development, production, and sale of prescription medications, with a focus on critical therapeutic areas such as cardiovascular, renal and metabolic disorders, immunology, and neuroscience. The processed food segment provides a wide array of items, from staple frozen goods like noodles and okonomiyaki, alongside frozen and pr…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	20.69×
P/S (TTM)	3.34×
P/B	3.10×
PEG	0.14×
P/FCF (TTM)	15.56×
EV / EBITDA	10.84×
EV / Sales	3.55×
Earnings Yield	4.83%
Free Cash Flow Yield	6.43%
Dividend Yield	3.70%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$13.56T
Revenue (TTM)	$3.83T
Net Income (TTM)	$617.29B
Free Cash Flow (TTM)	$972.66B
Net Debt	$786.13B
Working Capital	$1.80T
Gross Margin	57.55%
Operating Margin	25.06%
Net Margin	16.14%
Return on Equity	14.80%
Return on Invested Capital	9.73%